TriSalus Life Sciences, Inc.
NASDAQTriSalus Life Sciences enters Thursday's aftermath carrying a guidance cut, a target-price trim, and short interest at a six-week high — all in the same 48-hour window. The trigger was Tuesday's Q1 print. Revenue came in at $8.9M, missing the $10.4M consensus. EPS of $0.03 beat the $(0.16) estimate — an unusual combination of a top-line miss and a bottom-line beat. More damaging…
Snapshot as of 14 May 2026
TriSalus Life Sciences enters Thursday's aftermath carrying a guidance cut, a target-price trim, and short interest at a six-week high — all in the same 48-hour window. The trigger was Tuesday's Q1 print. Revenue came…
TriSalus Life Sciences heads into its May 14 earnings with short sellers adding positions at the fastest rate in months — yet the lending market remains far too relaxed to suggest anything close to a squeeze. Short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TLSI — free to start on ORTEX.
Sign up for free →Open TLSI on ORTEX